Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,635.00
+40.00 (0.87%)
At close: Dec 5, 2025
-28.91% (1Y)
| Market Cap | 52.46B |
| Revenue | n/a |
| Net Income | n/a |
| Shares Out | 11.32M |
| EPS | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 35.00 (0.76%) |
| Ex-Dividend Date | Sep 29, 2025 |
| Volume | 7,160 |
| Average Volume | 11,939 |
| Open | 4,560.00 |
| Previous Close | 4,595.00 |
| Day's Range | 4,560.00 - 4,640.00 |
| 52-Week Range | 4,355.00 - 8,840.00 |
| Beta | n/a |
| RSI | 32.13 |
| Earnings Date | Nov 27, 2025 |